In a 78-year-old man with sudden vision loss and optic disc edema consistent with anterior ischemic optic neuropathy, which of the following statements is incorrect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The INCORRECT Statement is B

The statement that "erythrocyte sedimentation rate (ESR) does not aid in the differential diagnosis" is INCORRECT. ESR is absolutely critical in differentiating arteritic from non-arteritic anterior ischemic optic neuropathy (AION), as it helps identify giant cell arteritis (temporal arteritis), which requires immediate high-dose corticosteroid treatment to prevent bilateral blindness 1.

Why Each Statement is Correct or Incorrect

Statement A: AION may be caused by temporal arteritis or diabetes mellitus - CORRECT

  • AION is divided into arteritic (most commonly giant cell arteritis/temporal arteritis) and nonarteritic types 1
  • Nonarteritic AION occurs in patients with underlying vascular risk factors such as hypertension and diabetes 1
  • Diabetes mellitus is a well-established risk factor for nonarteritic AION 2, 3

Statement B: ESR does not aid in differential diagnosis - INCORRECT

  • ESR is essential for distinguishing arteritic from nonarteritic AION 4
  • Clinical profile, sedimentation rate, and fluorescein angiography are very useful to make the distinction between nonarteritic and arteritic ION 4
  • An elevated ESR (along with C-reactive protein) raises suspicion for giant cell arteritis, which is a medical emergency requiring immediate treatment 5
  • The distinction is critical because arteritic AION requires urgent corticosteroid therapy, while nonarteritic AION does not have proven effective treatment 4, 6

Statement C: In posterior ION, the optic disc appears normal - CORRECT

  • Posterior ION is characterized by acute vision loss without initial disc edema but with subsequent optic disc atrophy 7
  • This contrasts with anterior ION, which presents with optic disc edema 1
  • The ischemia in posterior ION occurs in the retrobulbar optic nerve rather than at the optic nerve head 1

Statement D: Empiric corticosteroids without delay if temporal arteritis suspected - CORRECT

  • Treatment of temporal arteritis with steroids is an emergency 4
  • When arteritic AION (giant cell arteritis) is suspected, immediate high-dose corticosteroid treatment is mandatory to prevent progression to bilateral blindness
  • This should be initiated even before temporal artery biopsy confirmation, as delay can result in irreversible vision loss in the fellow eye

Statement E: Urgent ophthalmology referral - CORRECT

  • Given the sudden vision loss and optic disc edema, urgent ophthalmology evaluation is essential for:
    • Confirming the diagnosis
    • Performing detailed fundoscopic examination and visual field testing
    • Coordinating further workup including fluorescein angiography if needed 4
    • Monitoring for fellow eye involvement

Critical Clinical Pitfall

The most dangerous error in managing AION is failing to recognize arteritic AION (giant cell arteritis). Without immediate corticosteroid treatment, the fellow eye can become involved within days, resulting in bilateral blindness. ESR and C-reactive protein are screening tools that must be obtained urgently in any patient over 50 with sudden vision loss and optic disc edema 4, 5.

Related Questions

What is the most likely cause of sudden monocular vision loss in the right eye of a 72‑year‑old woman with acute punctate infarctions in the right frontal cortex and right putamen?
What is the treatment difference between Arteritic Anterior Ischemic Optic Neuropathy (AAION) and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)?
What are the symptoms of non-arteritic anterior ischemic optic neuropathy (NAION)?
What is the appropriate urgent evaluation and management for a 50-year-old woman presenting with sudden unilateral vision loss and a choroidal mass with surrounding subretinal fluid?
What psychological symptoms are associated with ocular stroke such as central retinal artery occlusion or ischemic optic neuropathy?
My upcoming appointment with my provider is on [date], and my comprehensive metabolic panel (CMP) and complete blood count (CBC) are within normal limits—do I need any further testing or medication changes before the visit?
Do Keppra (levetiracetam), Robaxin (methocarbamol), or Lyrica (pregabalin) affect insulin secretion or blood glucose levels?
Can ketorolac be administered to an elderly patient with a serum creatinine of 45 µmol/L?
Is there any immediate life‑threatening risk given my normal comprehensive metabolic panel, complete blood count, and lack of abnormal symptoms?
What is the most appropriate medication for treating recurrent anger outbursts in otherwise healthy adults?
In a 62‑year‑old man with dyslipidemia and impaired glucose tolerance who is currently off therapy and has total cholesterol 256 mg/dL, LDL‑C 172 mg/dL, triglycerides 204 mg/dL, HDL‑C 43 mg/dL, fasting glucose 106 mg/dL and HbA1c 6.1 %, should metformin and atorvastatin be started, and is a repeat oral glucose tolerance test indicated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.